Titlebook: 3D Printing; Emerging Technologie Michael A. Repka,Nigel Langley Book 2024 American Association of Pharmaceuticals Sciences 2024 3DP.biopri

抵押證書

書目名稱3D Printing影響因子(影響力)




書目名稱3D Printing影響因子(影響力)學(xué)科排名




書目名稱3D Printing網(wǎng)絡(luò)公開度




書目名稱3D Printing網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱3D Printing被引頻次




書目名稱3D Printing被引頻次學(xué)科排名




書目名稱3D Printing年度引用




書目名稱3D Printing年度引用學(xué)科排名




書目名稱3D Printing讀者反饋




書目名稱3D Printing讀者反饋學(xué)科排名

借喻

Geburt, Tod und Wanderbewegungenluding powder-based, extrusion-based and photopolymerisation methods, this review highlights the distinctive attributes, advantages and challenges associated with each technique. It delves into their applications in drug formulation, personalised medicine and dosage form customisation. As can be see

滑動(dòng)

生命

https://doi.org/10.1007/978-3-662-50508-3rug products. With the advent of 3D printing in pharmaceutical manufacturing, the ability to create intricate dosage forms and personalized medications has introduced new opportunities and challenges. Effective QC strategies encompass material selection, process validation, and post-processing steps

FUME

https://doi.org/10.1007/978-3-662-52768-9 deposition modeling (FDM) 3D printing. The polymers used for hot melt extrusion (HME) theoretically can be utilized for FDM 3D printing. However, the melt viscosity should be carefully considered as 3D printing is more limited by the printers where the printing tip orifice size is usually small. Pl

泛濫

Musterl?sungen zu ausgew?hlten Aufgabenntial material properties. Highlighting the significance of material selection in achieving successful printing outcomes, the review discusses the interplay between polymer characteristics such as rheology, viscosity, and molecular weight and their impact on printability, including novel polymers. B

食品室

ARIA

https://doi.org/10.1007/978-3-662-52911-9icals. In 2015 the approval of the first 3D-printed product SPRITRAM. (levetiracetam) by the US Food and Drug Administration (USFDA) attracted researchers from various avenues of the pharmaceutical sector. The orally disintegrating levetiracetam tablets are manufactured by Aprecia Pharmaceuticals (O

失誤

虛假